Indo Rama Synthetics (India) Ltd (INDORAMA) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Indo Rama Synthetics (India) Ltd on NSE and BSE, with an AI summary of each filing.
Transcript of Q2FY27 Earnings Conference Call held on 26.10.2026
Transcript · 02 Nov 2026, 9:51 pm
Audio Recording of Q2 FY27 Earnings Conference Call held on Monday, 26th October 2026, at 4:00 PM (IST).
Audio / Video · 27 Oct 2026, 12:42 am
Indo Rama Synthetics Releases Q2 FY27 Earnings Call Audio Recording Link Indo Rama Synthetics (India) Limited has released the audio recording link for its Q2 FY27 earnings conference call held on 26th Oct'26 at 4:00 PM IST. The call discussed the unaudited financial results for the quarter ended 30th Sep'26, which were previously approved by the Board of Directors on 16th Oct'26. The recording has been made publicly available on the company's official website in compliance with SEBI LODR Regulations.
Submission of Investor Presentation on the Un-audited Financial Results of the Company for the second quarter and half year ended 30 September, 2026.
Investor Presentation · 24 Oct 2026, 12:11 am
Indo Rama Synthetics Reports Strong Q2FY27 Results with 202% PAT Growth Indo Rama Synthetics delivered strong operational recovery in Q2FY27, with total income rising 10.0% YoY to Rs 1,344.0 crore. EBITDA surged 46.4% YoY to Rs 117.7 crore as margins expanded 220 bps to 8.8%. PAT grew 201.8% YoY to Rs 74.1 crore. For H1FY27, operating cash flows jumped 259.1% to Rs 329 crore, while net debt declined 23.5% to Rs 852 crore, improving debt-to-equity to 1.31x. The company approved ~Rs 200 crore capex for specialty filament and fibre expansion with an estimated payback of <2 years.
Submission of Investor Presentation on the unaudited Financial Results of the Company for the quarter and half year ended 30th September 2026.
Intimation · 24 Oct 2026, 12:01 am
Indo Rama Synthetics Reports Strong Q2FY27 Results With PAT Up 201.8% YoY Indo Rama Synthetics reported total income of Rs 1,344.0 cr in Q2FY27, up 10.0% YoY, while EBITDA expanded 46.4% YoY to Rs 117.7 cr with margins improving to 8.8%. PAT surged 201.8% YoY to Rs 74.1 cr. For H1FY27, PAT rose 78.3% YoY to Rs 137.8 cr, supported by higher capacity utilization and improved product mix. The board approved a ~Rs 200 cr capex for specialty filament and fibre expansion at Butibori, targeting commissioning in CY27 with an estimated payback period of under two years.
Intimation of Q2 FY27 Earnings Conference Call Scheduled for Monday, October 26,2026, at 4:00 PM (IST).
Intimation · 21 Oct 2026, 11:28 pm
Indo Rama Synthetics Schedules Q2 & H1 FY27 Earnings Call for 26th Oct'26 Indo Rama Synthetics (India) Limited will host its earnings conference call on 26th Oct'26 at 4:00 PM IST to discuss the unaudited financial performance for Q2 & H1 FY27, ended 30th Sep'26. The management team will be represented by Chairman & Managing Director Om Prakash Lohia, Chief Commercial and Financial Officer Umesh Kumar Agrawal, and Company Secretary Ashok Yadav. Universal dial-in numbers include +91 22 6280 1488 and +91 22 7115 8869, alongside international toll-free access for Hong Kong, Singapore, the UK, and the USA.
Submission of Press release
Press Release · 17 Oct 2026, 3:25 am
Indo Rama Synthetics Reports Strong Q2FY27 Results with 202% YoY PAT Growth Indo Rama Synthetics reported a 10.0% YoY rise in consolidated total income to ₹1,344.0 crore for Q2FY27 (up 43.0% QoQ). EBITDA grew 46.4% YoY to ₹117.7 crore, expanding margins by 220 bps to 8.8%. PAT surged 201.8% YoY to ₹74.1 crore with margins improving to 5.5%. For H1FY27, income fell 9.7% YoY to ₹2,284.2 crore due to Middle East supply disruptions, while PAT jumped 78.3% YoY to ₹137.8 crore. The company plans to invest ~₹200 crore over 12–18 months in specialty fibre and filaments.
Submission of Press Release
Press Release · 17 Oct 2026, 12:45 am
Indo Rama Synthetics Reports Strong Q2FY27 Results with 202% YoY PAT Growth Indo Rama Synthetics announced strong Q2FY27 financial results on 16th Oct'26, driven by solid margin expansion. Consolidated total income rose 10.0% YoY and 43.0% QoQ to ₹1,344.0 crore. EBITDA increased 46.4% YoY to ₹117.7 crore, with EBITDA margin expanding 220 bps to 8.8%. PAT surged 201.8% YoY to ₹74.1 crore as PAT margin reached 5.5% versus 2.0% in Q2FY26. To support medium-term growth, the company plans to invest approximately ₹200 crore over the next 12–18 months into value-added specialty fibre and filament products.
The Board of Directors, in their meeting held today, i.e., 16th October 2026, have interalia considered and approved expansion plan of approx. INR 200 Crores in the Company and its Wholly ....
Outcome · 16 Oct 2026, 8:40 pm
Indo Rama Synthetics Approves INR 200 Crore Specialty Capex Plan Indo Rama Synthetics' Board approved an expansion capex of approximately INR 200 Crores on 16th Oct'26 for the company and its wholly owned material subsidiary, Indorama Ventures Yarns Private Limited. The investment will fund specialty filament and specialty fibre production at its Butibori Plant in Nagpur, Maharashtra. Commercial operations are targeted within the next 12-18 months. The capex will be funded through a mix of term loans and internal accruals.
Submission of Financial Results
Financial Result · 16 Oct 2026, 8:27 pm
Indo Rama Synthetics (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Outcome · 16 Oct 2026, 8:25 pm
Indo Rama Synthetics (India) Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore) ■ Revenue: 1,341 (+9.8% YoY | +43.1% QoQ) ■ EBITDA: 112 (+63.4% YoY | +10.0% QoQ) ■ EBITDA Margin (%): 8.3 (+273 bps YoY | -251 bps QoQ) ■ PAT: 74.1 (+201.8% YoY | +16.2% QoQ) ■ EPS (INR): 2.84 (+202.1% YoY | +16.4% QoQ)
To consider and approve the financial results for the period ended September 30, 2026
Intimation · 16 Oct 2026, 5:30 am
Indo Rama Synthetics (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/10/2026 ,inter alia, to consider and approve un-audited Financial ....
Intimation · 16 Oct 2026, 5:30 am
Indo Rama Synthetics Board Meeting Scheduled on 16th Oct'26 for Q2 Results Indo Rama Synthetics (India) Limited has scheduled a meeting of its Board of Directors on 16th Oct'26 to consider and approve the un-audited standalone and consolidated financial results for the second quarter and half-year ended 30th Sep'26. In compliance with insider trading regulations, the trading window for dealing in company securities remains closed for designated persons from 1st Oct'26 to 18th Oct'26.
Indo Rama Synthetics (India) Limited has informed the Exchange about Board Meeting to be held on 16-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 .
Intimation · 16 Oct 2026, 5:30 am
Please find reply letter on clarification on price movement.
Others (Uncategorized) · 10 Sept 2026, 11:53 pm
Indo Rama Synthetics Clarifies Recent Share Price and Volume Movement to BSE Indo Rama Synthetics (India) Ltd. clarified to BSE on 10th Sep'26 regarding recent price movement, confirming full compliance with SEBI (LODR) Regulations, 2015. The company stated there is no undisclosed price-sensitive information, pending announcement, or corporate action impacting operations or performance. Management confirmed that the recent price and volume behaviour in the scrip is entirely market-driven and determined by prevailing market conditions, reiterating its commitment to promptly disclose any material events to the exchanges.
The Exchange has sought clarification from Indo Rama Synthetics (India) Ltd on September 10, 2026 with reference to significant movement in price, in order to ensure that investors have ....
Others (Uncategorized) · 10 Sept 2026, 11:09 pm
Disclosure under Regulations 7(2) of SEBI (PIT) Regulations, 2015
Others (Uncategorized) · 10 Sept 2026, 8:49 pm
Indo Rama Synthetics Promoter Urmila Lohia Acquires 4.15 Lakh Equity Shares Indo Rama Synthetics (India) Limited promoter Urmila Lohia acquired 4,14,796 equity shares via open market purchases on NSE between 8th Sep'26 and 9th Sep'26. The transaction comprised 2,17,137 shares bought on 8th Sep'26 for Rs 1.61 crore and 1,97,659 shares bought on 9th Sep'26 for Rs 1.53 crore, totaling Rs 3.14 crore. Following the acquisition, Lohia's total shareholding increased from 54,29,930 equity shares (20.76%) to 58,44,726 equity shares.
Submission of Voting Results along with Scrutinizer Report of 40th AGM of the Company held on September 8, 2026.
Annual General Meeting · 10 Sept 2026, 5:04 pm
Submission of summary of proceedings of the 40th Annual General Meeting of the Company held on September 8, 2026 at 11.30 a.m.
Annual General Meeting · 08 Sept 2026, 11:08 pm
Annual Report
Others (Uncategorized) · 17 Aug 2026, 10:40 pm
Fixation of cut-off date for the purpose of Annual General Meeting.
Annual General Meeting · 12 Aug 2026, 1:42 am
Outcome of Board Meeting held on July 29, 2026.
Outcome · 29 Jul 2026, 11:31 pm
Indo Rama Synthetics Q1FY27 Net Profit Rises Amidst Lower Revenue Indo Rama Synthetics' Q1FY27 consolidated net profit rose 20.8% YoY to ₹63.74 crore, despite a 28.2% YoY revenue decline to ₹936.64 crore, attributed to geopolitical volume impact. EBITDA grew 7.7% YoY to ₹108.04 crore, with margins expanding to 11.49% from 7.66% due to improved product mix. The board approved key re-appointments including Om Prakash Lohia as Chairman & MD for 3 years from 26 Dec'26, and Dharmpal Agarwal as Independent Director for 5 years from 25 Nov'26, pending shareholder approval.
Submission of Financial Results for the quarter ended June 30, 2026.
Financial Result · 29 Jul 2026, 11:18 pm
Indo Rama Synthetics (India) Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Crore) ■ Revenue: 937 (-28.3% YoY | -22.1% QoQ) ■ EBITDA: 102 (+11.8% YoY | -0.7% QoQ) ■ EBITDA Margin (%): 10.8 (+389 bps YoY | +233 bps QoQ) ■ PAT: 63.7 (+20.8% YoY | -0.6% QoQ) ■ EPS (INR): 2.44 (+20.8% YoY | -0.8% QoQ)
Appointment of Additional Directors in the category of Non-executive Independent Directors and re-constitution of Committees of the Board.
Change in Management · 28 Jul 2026, 3:28 am
Indo Rama Synthetics Appoints Two Independent Directors, Reconstitutes Board Committees Indo Rama Synthetics appointed Mrs. Ambika Sharma and Mr. Atim Kabra as Additional Non-Executive Independent Directors on 27th Jul'26, subject to shareholder approval. Both appointments are for an initial five-year term until 26th Jul'31. Mrs. Sharma brings experience from FICCI and USIBC, while Mr. Kabra has expertise in financial markets and serves on the board of Astra Microwave Products. The company also reconstituted its Audit, Nomination and Remuneration, and Stakeholders and Relationship committees, incorporating the new directors into key roles.
Indo Rama Synthetics (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2026 ,inter alia, to consider and approve unaudited results ....
Intimation · 29 Jul 2026, 5:30 am
Indo Rama Synthetics Board Meeting Set for Q1 Results Indo Rama Synthetics (India) Ltd. has scheduled a Board of Directors meeting on 29th Jul'26. The agenda includes consideration and approval of the un-audited standalone and consolidated financial results for the quarter ended 30th Jun'26. The trading window for designated persons is closed from 1st Jul'26 to 31st Jul'26, inclusive. The company's stock codes are NSE: INDORAMA and BSE: 500207.
Intimation for change of Board of Directors of the Company due to sad demise of Mr. Dhanendra Kumar, Independent Director.
Change in Management · 29 May 2026, 7:37 pm
Indo Rama Synthetics Announces Demise of Independent Director Indo Rama Synthetics (India) Ltd. announced the demise of Independent Director Mr. Dhanendra Kumar (DIN: 05019411) on 28th May'26. Consequently, he has ceased to be a Director on the company's Board and all its committees, effective from the same date. The change in directorship was filed under Regulation 30 of SEBI (LODR) Regulations, 2015. This creates a vacancy for an Independent Director position on the company's board.